Health
CRISPR screen identifies genes, drug targets to protect against SARS-CoV-2 infection – EurekAlert
Study demonstrates how changes in human genes can reduce SARS-CoV-2 infection and describes a wide array of genes that have not previously been considered as therapeutic…
IMAGE: Graphical abstract of the Cell study
view more
Credit: Sanjana Lab of New York Genome Center/New York University
NEW YORK, NY (October 26, 2020) – To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome. The team examined which genetic modifications…
-
Noosa News12 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business24 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News22 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General14 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle